Pharma sectors launch investment guidance cell
Tamil Nadu has about 450 drugs manufacturing companies and of them 120 units have WHO GMP facilities
By : DC Correspondent
Update: 2015-10-07 07:07 GMT
Chennai: Drawing an inspiration from the state’s September Global Investors Meet, the Tamil Nadu chapter of the Indian Drugs Manufacturers Association (TNIDMA) has created an Investment Guidance Cell (IGC) to attract foreign investments and also to highlight the huge potential available in the pharmaceutical sector in the state.
Tamil Nadu has about 450 drugs manufacturing companies and of them 120 units have WHO GMP facilities. Two big players have US FDA recognition and another two companies have UK MHRA facilities. Presently, the state lacks investment in business.
Through the cell, the promoters hope to transform the pharma sector into a vibrant and dynamic entrepreneurial area to attain growth. Tamil Nadu has a huge pool of pharma experts and scientists with pot-ential to take the industry to a very high level, it was pointed out.
It will give full guidance and knowledge to the international investors community about the pharma industry and its future growth prospects besides undertake the promotion activity of the investment areas in the pharmaceutical sector. Further it will promote the spirit of entrepreneurship among NRI investor community to use the potential of pharma sector in the state.
TN IDMA has decided to set up a guidance cell to attract more investment inflows to the pharma sector.